US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1053-2023
Class II · Moderate risk Terminated

HYDROmorphone added to 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1052-2023
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1051-2023
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1050-2023
Class II · Moderate risk Terminated

HYDROmorphone in dextrose 5%

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1049-2023
Class II · Moderate risk Terminated

vecuronium

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1048-2023
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1047-2023
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1046-2023
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1045-2023
Class II · Moderate risk Terminated

HYDROmorphone in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1044-2023
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1043-2023
Class II · Moderate risk Terminated

fentaNYL in dextrose 5%

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1042-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. NDC 72196-0215-1 D-1041-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1040-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1039-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1038-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1037-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1036-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1035-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1034-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1033-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1032-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1031-2023
Class II · Moderate risk Terminated

CARDIOPLEGIA SOLUTION 122 mEq K

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1030-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Central Admixture Pharmacy Services, Inc. D-1029-2023